BREAKING NEWS: HGS rejects GSK $2.60 billion takeover bid

Article Date: 19/04/2012 10:03
BREAKING NEWS: HGS rejects GSK $2.60 billion takeover bid

Vacancy Search

Quick job search

Advanced Search

Latest News

AZ' NSCLC drug clears first hurdle to early access in the UK

AZ' NSCLC drug clears first hurdle to early access in the UK

NICE turns down Celgene's Otezla for psoriatic arthritis

NICE turns down Celgene's Otezla for psoriatic arthritis

FDA approves AZ' Brilinta for long-term use

FDA approves AZ' Brilinta for long-term use

US regulators OK paediatric use of Merck's Emend

US regulators OK paediatric use of Merck's Emend

BMS files Opdivo for non-squamous NSCLC

BMS files Opdivo for non-squamous NSCLC

UCB sheds speciality generics unit for $1.23bn

UCB sheds speciality generics unit for $1.23bn

Barcodes, apps and free Wi-Fi on the cards for NHS patients

Barcodes, apps and free Wi-Fi on the cards for NHS patients

Novartis' Revolade wins EU nod for rare blood disorder

Novartis' Revolade wins EU nod for rare blood disorder

UPDATE: Amgen fails to block sale of Neupogen biosimilar

UPDATE: Amgen fails to block sale of Neupogen biosimilar

Daiichi buys license to AZ' flu vaccine in Japan

Daiichi buys license to AZ' flu vaccine in Japan
more news